期刊文献+

25,27-二(α,γ-二酮苯丁氧基)-26,28-二羟基杯[4]芳烃的合成 被引量:1

Synthesis of 25,27-di(α,γ-diketophenylbutoxy)-26,28-dihydroxy calix [4] arene
下载PDF
导出
摘要 以对叔丁基杯[4]芳烃为原料脱除叔丁基得到杯[4]芳烃,再经醚化、缩合两步反应首次合成25,27-二(α,γ-二酮苯丁氧基)-26,28-二羟基杯[4]芳烃,其结构经1H NMR、13C NMR、MS及元素分析表征。研究表明,目标化合物中的α,γ-二酮结构存在酮醇异构现象,在溶液中其酮醇异构体比例近似为1∶2。 25,27 -Di ( α,γ--diketophenylbutoxy) -26,28 -dihydroxy calix [ 4 ] arene was synthesized by a two-step reaction of etherifica- tion and condensation from calix [ 4 ] arene, which was prepared by p-tert-butylcalyx [ 4 ] arene as the raw material via dealkyla- tion. The structure of title compound was characterized by 1H NMR, ~3C NMR,MS and elemental analysis. The results also indicated that keto-enol tautomerism of the α,γ--diketo motif of the title compound was observed and the ratio of the keto-enol isomer approxi- mately was 1:2.
出处 《化学研究与应用》 CAS CSCD 北大核心 2013年第7期1046-1049,共4页 Chemical Research and Application
基金 国家自然科学基金青年科学基金项目(21102003)资助 安徽理工大学人才引进启动基金项目资助 安徽理工大学青年教师科学研究基金项目资助
关键词 杯[4]芳烃 α γ-二酮 合成 calix [ 4 ] arene α,γ-diketo synthesis
  • 相关文献

参考文献13

  • 1刘育,尤长城,张衡益.超分子化学——合成受体的识别与组装(第一版)[M].天津:南开大学出版社,2001:306-372.
  • 2RomanV R, Vyacheslav I B and Vitaly I K. Calixarenes inbio-medical researches [ J ]. Curr Med Chem, 2009, 16:1630-1 655.
  • 3MaximeM,Nicolas P,Geraldine L,et al. Synthesis and an-ti-HIV evaluation of water-soluble calixarene-based bithia-zolyl podands[ J]. Bioorg Med Chem,2010,18:36-45.
  • 4LunK T,Ginger E D,Elizabeth A G,et al. Discovery of asynthetic dual inhibitor of HIV and HCV infection basedon a tetrabutoxy-calix[4] arene scaffold [ J]. Bioorg MedChem Ie?,2010,20:2 137-2 139.
  • 5Pommier Y, Johnson A A, Marchand, C. Integrase inhibi-tors to treat HIV/Aids[ J]. Nat Rev Drug DiscoVery,2005,4:236-239.
  • 6Hazuda D J,FeIock P, Witmar M,et al. Inhibitors of strandtransfer that prevent integration and inhibit HIV-1 replica-tion in cells [ J ]. Science,2000,287 :646-650.
  • 7Wai J S,Egbertson M S,Payne L S,et al. 4-Aiyl-2,4-di-oxobutanoic acid inhibitors of HIV-1 integrase and viralreplication in cells [J], J Med Chem, 2000, 43 : 4 923-4 926.
  • 8Yoshinaga T,Sato A,Fujishita T,et al. S-1360:in vitro ac-tivity of a new HIV-1 integrase inhibitor in clinical devel-opment[J]_ Curr Opin Invest Drugs,2003,4 :206-209.
  • 9Ha2uda D J,Young S D,Guare J P,et al. Integrase inhibi-tors and cellular immunity suppress retroviral replicationin rhesus macaques[ J]. Science,2004,305:528-532.
  • 10SatoM,Motomura T, Aramaki H,et al. Novel HIV-1 inte-grase inhibitors derived from quinolone antibiotics[ J] . JMed Chem,2006,49:1 506-1 508.

二级参考文献5

  • 1王键吉,刘文彬,卓克垒,卢锦梭.杯芳烃应用研究的新进展[J].化学通报,1996(2):11-17. 被引量:12
  • 2Burlks R S, Fauke A R, Munch J H. Cyclic phenolaldehyde resins[ P]. US 4 259 464,1981.
  • 3Gutsche C D, Levine. Synthesis of a funetionalizable ealix[ 4 ] arene in a conformationally rigid cone conformarion[J]. J Am Chem Soc, 1982,104:2652-2653.
  • 4Gutsche C D, Levine J A, Sujeeth P K. Functionalized callxarenes : The claisen rearangement route [ J ]. J Org Chem, 1985,50:5802 - 5806.
  • 5Patrick T B, Egan P A. An improved preparation of phenolic [ 1.1.1.1 ] metacyelophanes [ J]. J Org Chem, 1977,42:382 - 383.

共引文献2

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部